CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹7,123 Cr | ₹6,291 Cr | ₹4,990 Cr | ₹4,512 Cr | ₹4,249 Cr |
What is the latest Operating Profit of CIPLA ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹7,123 Cr |
| Mar2025 | ₹6,291 Cr |
| Mar2024 | ₹4,990 Cr |
| Mar2023 | ₹4,512 Cr |
| Mar2022 | ₹4,249 Cr |
How is Operating Profit of CIPLA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,123 Cr | 13.22 | |
| Mar2025 | ₹6,291 Cr | 26.07 | |
| Mar2024 | ₹4,990 Cr | 10.60 | |
| Mar2023 | ₹4,512 Cr | 6.20 | |
| Mar2022 | ₹4,249 Cr | - | |
Compare Operating Profit of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹113,247.4 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| MANKIND PHARMA | ₹103,881.0 Cr | 1.1% | 1.2% | 3.6% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.6% |
4.4% |
-9.1% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses